The primary endpoint is to determine the number of days it takes to achieve a 50% reduction in blister count, and secondary endpoints include a reduction of baseline prednisone dose once the primary endpoint has been achieved. The trial will…
- Главная страница
- О нас
- Живущих с P/P
- Научные исследования
- Принять участие
- Новости & Информация о
- Discussion Forums
